SlideShare a Scribd company logo
1 of 13
Download to read offline
WP 5: IHR core capacity
strengthening and assessment
Anders Wallensten, Deputy State Epidemiologist
Public Health Agency of Sweden
15 October 2019
One Health Security Conference
• Background
• Task 5.1 - Improving IHR implementation
• Task 5.2 - International collaboration between authorities
during crisis
• Task 5.3 - IHR assessment using SimEx and AAR
Outline
• Objective: Support countries in building capacity required to
fulfill the requirements of IHR and EU Decision 1082/2013
• Achieved primarily by way of:
– A) Workshops aimed to support IHR implementation for low GNI countries
(Task 5.1)
– B) Workshops on international collaboration between authorities during
crisis (Task 5.2)
– C) Continued work on After Action Evaluations (Task 5.3)
• Leaders: Public Health Agency of Sweden
• Co-Leader: Norwegian Directorate of Health
• Affiliate: Norwegian Institute of Public Health
Background
Report
improving IHR
imp. M16
Checkpoint 1
M10
Checkpoint 2
M16
Review of JEE,
IHR & ECDC
reports & tools
Gathering input
from WP
Partners
Determining
Work Plan
Start-up
Meeting
4 July
Report
D5.2 M36
Checkpoint 5
M 34
WS SI
M34
WS PL
M22
Checkpoint 4
M28
Checkpoint 3
M22
Report
improving IHR
imp. M24
WS LV
M10
January
M1 M12 M24
Timeline for Task 5.1: Improving
IHR implementation
• Twelve low GNI countries are part of the WP:
Task 5.1: Improving IHR implementation
Bosnia and Herzegovina
Croatia
Greece
Latvia
Lithuania
Malta
Republic of Moldova
Poland
Portugal
Serbia
Slovenia
Spain
• Overall capacity of WP5 10 countries = 69.5%
– European average is 73%
• The highest scores were in the areas:
– C1 Legislation and financing (84.1%)
– C4 Food Safety (82%)
– C2 IHR Coordination & NFP Functions (79%)
Highest Scores - SPAR Reports
Source: Using results from World Health
Organization. Electronic State Parties Self-Assessment
Annual Reporting Tool. https://extranet.who.int/e-
spar#capacity-score
C10 Risk communication (56%) (20%-80%)
C11 Points of entry (57%) (0-80%)
C12 Chemical events (58%) (20%-80%)
C.5.2 Implementation of a laboratory
biosafety and biosecurity regime (60%)
Overall C5.2 range
(33%-100%)
C8 National health emergency framework
(64.7%)
(20%-93)
C13 Radiation (66%) (40%-100%)
C3 Zoonotic events and the human-
animal interface (66%)
(20% - 80%)
Areas for improvement – SPAR Reports
Source: Using results from World Health
Organization. Electronic State Parties Self-Assessment
Annual Reporting Tool. https://extranet.who.int/e-
spar#capacity-score
• Five low GNI Countries in WP5 have done a JEE
Within the scope of WP5 the areas seen for improvement
– Antimicrobial stewardship activities (P.3.4)
– Biosafety and biosecurity (P.6.1 and P.6.2)
– Risk Communication (R.5.1 and R. 5.4)
– Chemicals (CE.1 and CE.2)
Areas for improvement – JEE Reports
Source: Using results from World Health
Organization. Joint External Evaluation Reports for
Latvia, Lithuania, Slovenia, Serbia and Republic of
Moldova
• Strengthen preparedness and the implementation of IHR
and EU Decision 1082/2013
• Improving cross-sectoral (medical and civil protection)
preparedness and response capacity in Member States and
within EU
• Strengthening information exchange, cross-sectoral
response and mechanisms for rapid mobilization health
personnel and medical countermeasures across borders
Task 5.2 Objectives: International
collaboration between authorities during crisis
• Challenges to capacity, preparedness and response
• Gaps in roles and responsibilities; Member States, DG ECHO,
DG SANTE and WHO
• Identify legal and organizational issues in cross-border, cross
sectoral response to health threats and emergencies, for
example:
– Issues on authorization of health care personnel
– Health systems response and cooperation – procedures,
management and confidentiality
– Predictability on financial issues and reimbursement
Implementation Process 5.2 Prioritising WS
Topics
• Identify relevant health and civil authorities in the Member
States and invite them to collaborate
• M18 WS on legal issues: what are the main obstacles
against receiving help or assisting others
• M 34 WS in Portugal: Competent authorities from health and
civil protection (one from each) in line with the workshop
objectives.
• Report
Timeline for Task 5.2: Improving IHR
implementation
Task 5.3: Using data from SimEx and AAR for assessing
public health preparedness in the EU
• Background
– SimEx and AAR part of IHR monitoring framework
– Highlight more operational gaps and challenges
– Complement Annual self assessment and JEE
• Support WHO EURO in MS survey on SimEx and AAR
conducted in countries
– Overview of what is done in countries
– Main gaps and recommendations identified
– Main challenges in implementation
• Review of EU exercises (tbd with ECDC and the EC)
https://apps.who.int/iris/bitstream/handle/10665/276651/WHO-WHE-CPI-2018.51-eng.pdf?sequence=1
Primary contact points WP5
Anders Wallensten Public Health Agency of Sweden
Svein Høegh Henrichsen Norwegian Directorate of Health
Karin Nygård Norwegian Institute of Public Health
Thank you!

More Related Content

What's hot

Rebecca Katz: Challenges in Global Health Security
Rebecca Katz: Challenges in Global Health SecurityRebecca Katz: Challenges in Global Health Security
Rebecca Katz: Challenges in Global Health SecurityTHL
 
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...THL
 
Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...
Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...
Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...THL
 
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)THL
 
OS20 - California FMD vaccination planning - L. Quiroz/ P. Hullinger
OS20 -  California FMD vaccination planning  - L. Quiroz/ P. HullingerOS20 -  California FMD vaccination planning  - L. Quiroz/ P. Hullinger
OS20 - California FMD vaccination planning - L. Quiroz/ P. HullingerEuFMD
 
Inventory among DEMETER Stakeholders on EMERGING RISKS Systems
Inventory among DEMETER Stakeholders on EMERGING RISKS SystemsInventory among DEMETER Stakeholders on EMERGING RISKS Systems
Inventory among DEMETER Stakeholders on EMERGING RISKS SystemsAGINFRA
 
GS43_8. Hold-FAST. strategy
GS43_8. Hold-FAST. strategyGS43_8. Hold-FAST. strategy
GS43_8. Hold-FAST. strategyEuFMD
 
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...THL
 
Risk assessment of potential health threats – Enhancing disease surveillance ...
Risk assessment of potential health threats – Enhancing disease surveillance ...Risk assessment of potential health threats – Enhancing disease surveillance ...
Risk assessment of potential health threats – Enhancing disease surveillance ...Global Risk Forum GRFDavos
 
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...EuFMD
 
Future Health Challenges: Developing Global Norms for Data and Results Sharin...
Future Health Challenges: Developing Global Norms for Data and Results Sharin...Future Health Challenges: Developing Global Norms for Data and Results Sharin...
Future Health Challenges: Developing Global Norms for Data and Results Sharin...ExternalEvents
 
Os20 - Prioritization of vaccines – approaches to maximizing impact - Alasdai...
Os20 - Prioritization of vaccines – approaches to maximizing impact - Alasdai...Os20 - Prioritization of vaccines – approaches to maximizing impact - Alasdai...
Os20 - Prioritization of vaccines – approaches to maximizing impact - Alasdai...EuFMD
 
OS20 - Factors influencing decision-making for foot-and-mouth disease contro...
OS20 -  Factors influencing decision-making for foot-and-mouth disease contro...OS20 -  Factors influencing decision-making for foot-and-mouth disease contro...
OS20 - Factors influencing decision-making for foot-and-mouth disease contro...EuFMD
 
From risk regulation to innovation democracy
From risk regulation to innovation democracyFrom risk regulation to innovation democracy
From risk regulation to innovation democracyEFSA EU
 
Mahoney Panama Dpb July 2009 V2
Mahoney Panama Dpb July 2009 V2Mahoney Panama Dpb July 2009 V2
Mahoney Panama Dpb July 2009 V2gambelguy
 

What's hot (20)

Rebecca Katz: Challenges in Global Health Security
Rebecca Katz: Challenges in Global Health SecurityRebecca Katz: Challenges in Global Health Security
Rebecca Katz: Challenges in Global Health Security
 
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...
Johanna Takkinen: Operational Collaboration on EU-wide Zoonotic and Foodborne...
 
Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...
Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...
Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...
 
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)
 
OS20 - California FMD vaccination planning - L. Quiroz/ P. Hullinger
OS20 -  California FMD vaccination planning  - L. Quiroz/ P. HullingerOS20 -  California FMD vaccination planning  - L. Quiroz/ P. Hullinger
OS20 - California FMD vaccination planning - L. Quiroz/ P. Hullinger
 
European Commission support actions for laboratory preparedness
European Commission support actions for laboratory preparednessEuropean Commission support actions for laboratory preparedness
European Commission support actions for laboratory preparedness
 
Inventory among DEMETER Stakeholders on EMERGING RISKS Systems
Inventory among DEMETER Stakeholders on EMERGING RISKS SystemsInventory among DEMETER Stakeholders on EMERGING RISKS Systems
Inventory among DEMETER Stakeholders on EMERGING RISKS Systems
 
GS43_8. Hold-FAST. strategy
GS43_8. Hold-FAST. strategyGS43_8. Hold-FAST. strategy
GS43_8. Hold-FAST. strategy
 
Global Health Security Agenda GHSA
Global Health Security Agenda GHSAGlobal Health Security Agenda GHSA
Global Health Security Agenda GHSA
 
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...
Anni Virolainen-Julkunen: Joint External Evaluations (JEE) – Country experien...
 
Risk assessment of potential health threats – Enhancing disease surveillance ...
Risk assessment of potential health threats – Enhancing disease surveillance ...Risk assessment of potential health threats – Enhancing disease surveillance ...
Risk assessment of potential health threats – Enhancing disease surveillance ...
 
ECDC preparedness work: How ECDC is supporting the Commission and the Member ...
ECDC preparedness work: How ECDC is supporting the Commission and the Member ...ECDC preparedness work: How ECDC is supporting the Commission and the Member ...
ECDC preparedness work: How ECDC is supporting the Commission and the Member ...
 
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
 
The WHO/WPPRO Preparedness Strategy for EIDs
The WHO/WPPRO Preparedness Strategy for EIDsThe WHO/WPPRO Preparedness Strategy for EIDs
The WHO/WPPRO Preparedness Strategy for EIDs
 
Future Health Challenges: Developing Global Norms for Data and Results Sharin...
Future Health Challenges: Developing Global Norms for Data and Results Sharin...Future Health Challenges: Developing Global Norms for Data and Results Sharin...
Future Health Challenges: Developing Global Norms for Data and Results Sharin...
 
Os20 - Prioritization of vaccines – approaches to maximizing impact - Alasdai...
Os20 - Prioritization of vaccines – approaches to maximizing impact - Alasdai...Os20 - Prioritization of vaccines – approaches to maximizing impact - Alasdai...
Os20 - Prioritization of vaccines – approaches to maximizing impact - Alasdai...
 
Regional strategy to improve access to medicines and vaccines in the Eastern ...
Regional strategy to improve access to medicines and vaccines in the Eastern ...Regional strategy to improve access to medicines and vaccines in the Eastern ...
Regional strategy to improve access to medicines and vaccines in the Eastern ...
 
OS20 - Factors influencing decision-making for foot-and-mouth disease contro...
OS20 -  Factors influencing decision-making for foot-and-mouth disease contro...OS20 -  Factors influencing decision-making for foot-and-mouth disease contro...
OS20 - Factors influencing decision-making for foot-and-mouth disease contro...
 
From risk regulation to innovation democracy
From risk regulation to innovation democracyFrom risk regulation to innovation democracy
From risk regulation to innovation democracy
 
Mahoney Panama Dpb July 2009 V2
Mahoney Panama Dpb July 2009 V2Mahoney Panama Dpb July 2009 V2
Mahoney Panama Dpb July 2009 V2
 

Similar to Anders Wallensten: SHARP WP5 Brief Introduction – Strengthening IHR Core Capacities

eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
eHealth Tools & Services: Needs of the Member States Report of the WHO Global...eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
eHealth Tools & Services: Needs of the Member States Report of the WHO Global...Dr Lendy Spires
 
Implementing eHealth: from pilot to practice
Implementing eHealth: from pilot to practiceImplementing eHealth: from pilot to practice
Implementing eHealth: from pilot to practiceAnna Kotzeva
 
Presentation: Global pharmacovigilance networks - A regulator's
Presentation: Global pharmacovigilance networks - A regulator'sPresentation: Global pharmacovigilance networks - A regulator's
Presentation: Global pharmacovigilance networks - A regulator'sTGA Australia
 
Carbon Footprinting and Healthcare
Carbon Footprinting and HealthcareCarbon Footprinting and Healthcare
Carbon Footprinting and HealthcareUNDP Eurasia
 
Introduction to the Progressive Control Pathway
Introduction to the Progressive Control PathwayIntroduction to the Progressive Control Pathway
Introduction to the Progressive Control PathwayFAO
 
Progetto sugli Stili di vita (Roberto Della Vedova)
Progetto sugli Stili di vita (Roberto Della Vedova)Progetto sugli Stili di vita (Roberto Della Vedova)
Progetto sugli Stili di vita (Roberto Della Vedova)csermeg
 
Management of patient information trends and challenges in member states
Management of patient information trends and challenges in member statesManagement of patient information trends and challenges in member states
Management of patient information trends and challenges in member statesDr Lendy Spires
 
Development of a Progressive Management Pathway to assist National and Intern...
Development of a Progressive Management Pathway to assist National and Intern...Development of a Progressive Management Pathway to assist National and Intern...
Development of a Progressive Management Pathway to assist National and Intern...EuFMD
 
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...EUnetHTA
 
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...Martin Pan
 
Changes in European PV post July 2011
Changes in European PV post July 2011Changes in European PV post July 2011
Changes in European PV post July 2011Amrutha VC
 
ILF Chronic Oedema Outcomes Project
ILF Chronic Oedema Outcomes ProjectILF Chronic Oedema Outcomes Project
ILF Chronic Oedema Outcomes ProjectMary Fickling
 
Accelerating implementation of the International Health Regulations (2005) an...
Accelerating implementation of the International Health Regulations (2005) an...Accelerating implementation of the International Health Regulations (2005) an...
Accelerating implementation of the International Health Regulations (2005) an...WHO Regional Office for Europe
 
Telemedicine opportunities and development in member states
Telemedicine opportunities and development in member statesTelemedicine opportunities and development in member states
Telemedicine opportunities and development in member statesDr Lendy Spires
 
Small County Strategic Planning Presentation v1.2
Small County Strategic Planning Presentation  v1.2Small County Strategic Planning Presentation  v1.2
Small County Strategic Planning Presentation v1.2Saumitra SenGupta
 
Rosarie lynch, EPA, HSE and ESRI, Environment, Health and Wellbeing Conferenc...
Rosarie lynch, EPA, HSE and ESRI, Environment, Health and Wellbeing Conferenc...Rosarie lynch, EPA, HSE and ESRI, Environment, Health and Wellbeing Conferenc...
Rosarie lynch, EPA, HSE and ESRI, Environment, Health and Wellbeing Conferenc...Environmental Protection Agency, Ireland
 

Similar to Anders Wallensten: SHARP WP5 Brief Introduction – Strengthening IHR Core Capacities (20)

eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
eHealth Tools & Services: Needs of the Member States Report of the WHO Global...eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
 
Progress report on the implementation of the International Health Regulations...
Progress report on the implementation of the International Health Regulations...Progress report on the implementation of the International Health Regulations...
Progress report on the implementation of the International Health Regulations...
 
Implementing eHealth: from pilot to practice
Implementing eHealth: from pilot to practiceImplementing eHealth: from pilot to practice
Implementing eHealth: from pilot to practice
 
Hospital organisation, management and structure for prevention of HAI. Walter...
Hospital organisation, management and structure for prevention of HAI. Walter...Hospital organisation, management and structure for prevention of HAI. Walter...
Hospital organisation, management and structure for prevention of HAI. Walter...
 
Presentation: Global pharmacovigilance networks - A regulator's
Presentation: Global pharmacovigilance networks - A regulator'sPresentation: Global pharmacovigilance networks - A regulator's
Presentation: Global pharmacovigilance networks - A regulator's
 
Carbon Footprinting and Healthcare
Carbon Footprinting and HealthcareCarbon Footprinting and Healthcare
Carbon Footprinting and Healthcare
 
Introduction to the Progressive Control Pathway
Introduction to the Progressive Control PathwayIntroduction to the Progressive Control Pathway
Introduction to the Progressive Control Pathway
 
Progetto sugli Stili di vita (Roberto Della Vedova)
Progetto sugli Stili di vita (Roberto Della Vedova)Progetto sugli Stili di vita (Roberto Della Vedova)
Progetto sugli Stili di vita (Roberto Della Vedova)
 
Management of patient information trends and challenges in member states
Management of patient information trends and challenges in member statesManagement of patient information trends and challenges in member states
Management of patient information trends and challenges in member states
 
Development of a Progressive Management Pathway to assist National and Intern...
Development of a Progressive Management Pathway to assist National and Intern...Development of a Progressive Management Pathway to assist National and Intern...
Development of a Progressive Management Pathway to assist National and Intern...
 
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
 
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
 
Changes in European PV post July 2011
Changes in European PV post July 2011Changes in European PV post July 2011
Changes in European PV post July 2011
 
ILF Chronic Oedema Outcomes Project
ILF Chronic Oedema Outcomes ProjectILF Chronic Oedema Outcomes Project
ILF Chronic Oedema Outcomes Project
 
Accelerating implementation of the International Health Regulations (2005) an...
Accelerating implementation of the International Health Regulations (2005) an...Accelerating implementation of the International Health Regulations (2005) an...
Accelerating implementation of the International Health Regulations (2005) an...
 
Telemedicine opportunities and development in member states
Telemedicine opportunities and development in member statesTelemedicine opportunities and development in member states
Telemedicine opportunities and development in member states
 
D2 pl-02-e-who gpw13 impact measurement
D2 pl-02-e-who gpw13 impact measurementD2 pl-02-e-who gpw13 impact measurement
D2 pl-02-e-who gpw13 impact measurement
 
Small County Strategic Planning Presentation v1.2
Small County Strategic Planning Presentation  v1.2Small County Strategic Planning Presentation  v1.2
Small County Strategic Planning Presentation v1.2
 
New approach for assessing and monitoring the implementation of the Internati...
New approach for assessing and monitoring the implementation of the Internati...New approach for assessing and monitoring the implementation of the Internati...
New approach for assessing and monitoring the implementation of the Internati...
 
Rosarie lynch, EPA, HSE and ESRI, Environment, Health and Wellbeing Conferenc...
Rosarie lynch, EPA, HSE and ESRI, Environment, Health and Wellbeing Conferenc...Rosarie lynch, EPA, HSE and ESRI, Environment, Health and Wellbeing Conferenc...
Rosarie lynch, EPA, HSE and ESRI, Environment, Health and Wellbeing Conferenc...
 

More from THL

Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021THL
 
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdfNiiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdfTHL
 
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdfYlitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdfTHL
 
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdfNieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdfTHL
 
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdfRaitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdfTHL
 
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...THL
 
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdfLansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdfTHL
 
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdfMarkkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdfTHL
 
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022THL
 
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilastoRikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilastoTHL
 
Synthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in EuropeSynthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in EuropeTHL
 
Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021THL
 
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022THL
 
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdfAktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdfTHL
 
Kort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationerKort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationerTHL
 
Förvaring av vacciner
Förvaring av vaccinerFörvaring av vacciner
Förvaring av vaccinerTHL
 
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...THL
 
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikatauluHanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikatauluTHL
 
Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022THL
 
Tietoisku eri rokotteista
Tietoisku eri rokotteistaTietoisku eri rokotteista
Tietoisku eri rokotteistaTHL
 

More from THL (20)

Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021
 
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdfNiiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
 
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdfYlitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
 
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdfNieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
 
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdfRaitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
 
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
 
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdfLansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
 
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdfMarkkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
 
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
 
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilastoRikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
 
Synthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in EuropeSynthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in Europe
 
Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021
 
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
 
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdfAktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
 
Kort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationerKort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationer
 
Förvaring av vacciner
Förvaring av vaccinerFörvaring av vacciner
Förvaring av vacciner
 
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
 
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikatauluHanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
 
Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022
 
Tietoisku eri rokotteista
Tietoisku eri rokotteistaTietoisku eri rokotteista
Tietoisku eri rokotteista
 

Recently uploaded

Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 

Recently uploaded (20)

Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 

Anders Wallensten: SHARP WP5 Brief Introduction – Strengthening IHR Core Capacities

  • 1. WP 5: IHR core capacity strengthening and assessment Anders Wallensten, Deputy State Epidemiologist Public Health Agency of Sweden 15 October 2019 One Health Security Conference
  • 2. • Background • Task 5.1 - Improving IHR implementation • Task 5.2 - International collaboration between authorities during crisis • Task 5.3 - IHR assessment using SimEx and AAR Outline
  • 3. • Objective: Support countries in building capacity required to fulfill the requirements of IHR and EU Decision 1082/2013 • Achieved primarily by way of: – A) Workshops aimed to support IHR implementation for low GNI countries (Task 5.1) – B) Workshops on international collaboration between authorities during crisis (Task 5.2) – C) Continued work on After Action Evaluations (Task 5.3) • Leaders: Public Health Agency of Sweden • Co-Leader: Norwegian Directorate of Health • Affiliate: Norwegian Institute of Public Health Background
  • 4. Report improving IHR imp. M16 Checkpoint 1 M10 Checkpoint 2 M16 Review of JEE, IHR & ECDC reports & tools Gathering input from WP Partners Determining Work Plan Start-up Meeting 4 July Report D5.2 M36 Checkpoint 5 M 34 WS SI M34 WS PL M22 Checkpoint 4 M28 Checkpoint 3 M22 Report improving IHR imp. M24 WS LV M10 January M1 M12 M24 Timeline for Task 5.1: Improving IHR implementation
  • 5. • Twelve low GNI countries are part of the WP: Task 5.1: Improving IHR implementation Bosnia and Herzegovina Croatia Greece Latvia Lithuania Malta Republic of Moldova Poland Portugal Serbia Slovenia Spain
  • 6. • Overall capacity of WP5 10 countries = 69.5% – European average is 73% • The highest scores were in the areas: – C1 Legislation and financing (84.1%) – C4 Food Safety (82%) – C2 IHR Coordination & NFP Functions (79%) Highest Scores - SPAR Reports Source: Using results from World Health Organization. Electronic State Parties Self-Assessment Annual Reporting Tool. https://extranet.who.int/e- spar#capacity-score
  • 7. C10 Risk communication (56%) (20%-80%) C11 Points of entry (57%) (0-80%) C12 Chemical events (58%) (20%-80%) C.5.2 Implementation of a laboratory biosafety and biosecurity regime (60%) Overall C5.2 range (33%-100%) C8 National health emergency framework (64.7%) (20%-93) C13 Radiation (66%) (40%-100%) C3 Zoonotic events and the human- animal interface (66%) (20% - 80%) Areas for improvement – SPAR Reports Source: Using results from World Health Organization. Electronic State Parties Self-Assessment Annual Reporting Tool. https://extranet.who.int/e- spar#capacity-score
  • 8. • Five low GNI Countries in WP5 have done a JEE Within the scope of WP5 the areas seen for improvement – Antimicrobial stewardship activities (P.3.4) – Biosafety and biosecurity (P.6.1 and P.6.2) – Risk Communication (R.5.1 and R. 5.4) – Chemicals (CE.1 and CE.2) Areas for improvement – JEE Reports Source: Using results from World Health Organization. Joint External Evaluation Reports for Latvia, Lithuania, Slovenia, Serbia and Republic of Moldova
  • 9. • Strengthen preparedness and the implementation of IHR and EU Decision 1082/2013 • Improving cross-sectoral (medical and civil protection) preparedness and response capacity in Member States and within EU • Strengthening information exchange, cross-sectoral response and mechanisms for rapid mobilization health personnel and medical countermeasures across borders Task 5.2 Objectives: International collaboration between authorities during crisis
  • 10. • Challenges to capacity, preparedness and response • Gaps in roles and responsibilities; Member States, DG ECHO, DG SANTE and WHO • Identify legal and organizational issues in cross-border, cross sectoral response to health threats and emergencies, for example: – Issues on authorization of health care personnel – Health systems response and cooperation – procedures, management and confidentiality – Predictability on financial issues and reimbursement Implementation Process 5.2 Prioritising WS Topics
  • 11. • Identify relevant health and civil authorities in the Member States and invite them to collaborate • M18 WS on legal issues: what are the main obstacles against receiving help or assisting others • M 34 WS in Portugal: Competent authorities from health and civil protection (one from each) in line with the workshop objectives. • Report Timeline for Task 5.2: Improving IHR implementation
  • 12. Task 5.3: Using data from SimEx and AAR for assessing public health preparedness in the EU • Background – SimEx and AAR part of IHR monitoring framework – Highlight more operational gaps and challenges – Complement Annual self assessment and JEE • Support WHO EURO in MS survey on SimEx and AAR conducted in countries – Overview of what is done in countries – Main gaps and recommendations identified – Main challenges in implementation • Review of EU exercises (tbd with ECDC and the EC) https://apps.who.int/iris/bitstream/handle/10665/276651/WHO-WHE-CPI-2018.51-eng.pdf?sequence=1
  • 13. Primary contact points WP5 Anders Wallensten Public Health Agency of Sweden Svein Høegh Henrichsen Norwegian Directorate of Health Karin Nygård Norwegian Institute of Public Health Thank you!